EDITORIAL SECTION
-
STRATEGY
Strategic Positioning for M&A
The biotechnology sector is characterised by a constant influx of small highly specialised companies
-
RESEARCH DEVELOPMENT
Cytiva Laboratory capsule filters
Our singleuse selfcontained filtration solutions help reduce contamination risk and lower manual handling
-
CLINICAL TRIALS
Virtual Clinical Trials
Virtual digital and decentralized are all descriptions of the novel ways that using technology changes
-
Bio Pharma
Biosimilars and Biobetters
Biosimilars are biologic medical products that are essentially identical to an original product manufactured
-
MANUFACTURING
Transformative Convergence of AI in Pharmaceutical Manufacturing
The pharmaceutical manufacturing industry is on the cusp of a revolutionary transformation driven by
-
Information Technology
Transformative Impact of Artificial Intelligence on Clinical Trials
Artificial Intelligence AI has rapidly evolved from a futuristic concept to a transformative tool across various industries
-
EXPERT Talk
Pharma's Medical Affairs Bridge: From Field Insights and Stakeholder Needs to Global Scientific Strategy
Medical Affairs has evolved from being primarily a supportive and educational function to becoming a strong strategic partner earlier on Through ongoi...
Advisory Board
.webp "Juris Hmelnickis")
.webp "Eiman Shafa")
KNOWLEDGE BANK
-
Articles
How Decentralized Clinical Trials Are Changing U.S. Research
For most of its history the American clinical trial has been built around a single location the research site Participants were expected to travel often repeatedly to an academic medical center or specialist clinic for screening dosing blood draws and questionnaires That model produced rigorous science but it also produced familiar frustrations for pharmaceutical sponsors including slow recruitmen...
-
Techno Trends
Lilly’s Jaypirca Gains FDA Approval for First-Line CLL/SLL Treatment
Eli Lilly and Company has received approval from the US Food and Drug Administration FDA for an additional indication for Jaypirca pirtobrutinib in adults with previously untreated chronic lymphocytic leukaemia CLL or small lymphocytic lymphoma SLL without a known p deletion The approval enables Jaypirca to be used as a firstline treatment
-
Projects
Genentech Begins US$750 Million Expansion of Oregon Manufacturing Facility
Genentech a member of the Roche Group has started construction on a US million expansion of its manufacturing facility in Hillsboro Oregon The squarefoot project will double the existing sites footprint and increase US production capacity for advanced drug delivery devices
-
Research Insights
Identification of flavonoids from natural products against hyperlipidaemia through computational approaches
Over the centuries hyperlipidaemia has been recognised as a major risk factor contributing to cardiovascular disease CVD Current research increasingly explores natural compounds such as flavonoids for their potential lipidlowering effects This study evaluated pharmacological potential
-
White Papers
Post-Translational Modifications in Drug Discovery: From Molecular Regulation to Clinical Impact
For decades the central dogma of molecular biology has anchored our understanding of cellular function DNA to RNA to protein But this linear view is incomplete A growing body of evidence shows that much of biologys complexity
TOP ARTICLES
-
1
B2B Pharma Content Strategy for HCP Engagement and Multi-Channel Marketing
Kate Williamson
Healthcare professionals increasingly expect personalized, evidence-based interactions across multiple touchpoints. This article explores how pharmaceutical companies can strengthen HCP engagement thr...
-
2
Continuous Manufacturing: The New Standard for Agile Pharma Production
Lakshmi
Continuous manufacturing has moved from demonstration to expectation. This article examines what it changes in the control strategy rather than merely the equipment, the economics American executives...
-
3
Beyond GLP-1: Emerging Biologic Therapies Reshaping Chronic Disease Care
Lakshmi
GLP-1 receptor agonists redrew the commercial map of chronic disease, but they are a preview rather than a peak. A second wave of pharmaceutical biologics — TL1A antibodies, engineered bispecifi...
-
4
How Biosimilars Are Changing Competition in the U.S. Drug Market
Lakshmi
Biosimilars have saved the U.S. healthcare system $81.6 billion since 2015, yet their real impact is strategic rather than purely financial. This article examines how biosimilars are reshaping competi...
-
5
Forgotten Biology: The Missing Link Behind Trial Outcomes
Dr. Sachin Dighe
Mr. Jayesh Chaudhary
Trial failure is not always a product failure; often, it is a population-design failure. This article explores how overlooked biological heterogeneity weakens signals, obscures efficacy and undermines...
press releasesRead more...
Guardian Pharmacy Services Acquires Van’s Institutional Pharmacy, Expanding Footprint in Tennessee and Kentucky
Guardian Pharmacy Services Inc one of the nations largest and most innovative longterm care LTC pharmacy services companies today announced the acquisition of Vans Institutional Pharmacy an LTC pharmacy based in Martin Tenn The addition grows Guardians Tennessee operations to five pharmacies
Immunome Announces EMA Validation of Marketing Authorization Application for Varegacestat for the Treatment of Adults with Desmoid Tumors
Immunome Inc a clinicalstage targeted oncology company committed to developing firstinclass and bestinclass targeted cancer therapies today announced that the European Medicines Agency EMA has validated the Marketing Authorization Application MAA for varegacestat an investigational oral oncedaily ga...
ILUMYA® (tildrakizumab-asmn) approved in the U.S. for the Treatment of Adults with Active Psoriatic Arthritis
Sun Pharmaceutical Industries Limited Reuters SUNBO Bloomberg SUNP IN NSE SUNPHARMA BSE Sun Pharma and includes its subsidiaries andor associated companies announced today that the US Food and Drug Administration FDA has approved the supplemental Biologics License Application
Eloxx Pharmaceuticals Announces FDA Clearance of Investigational New Drug Application for Exaluren in Nonsense-Mutation ADPKD
Eloxx Pharmaceuticals Inc a clinicalstage biopharmaceutical company developing exaluren for the treatment of rare kidney diseases today announced that the US Food and Drug Administration FDA has cleared the Companys Investigational New Drug IND application for exaluren for the treatment of nonsensem...
Events Read more...
02 - 04
Nov 2026Pharma Forum EMEA 2026
Dom Pedro Lisboa Hotel, Lisbon...
02 - 04
Nov 2026Cancer R&D 2026
Houston, TX, USA
03 - 05
Nov 202610th Dermatology Drug Development
Boston, Massachusetts at The C...
03 - 04
Nov 2026PDA Aseptic Processing of Biopharma Conference
Sheraton Grand Incheon Hotel,...
04 - 05
Nov 2026Advanced Therapies USA
Hynes Convention Center, Bosto...
05 - 05
Nov 2026PDA Contamination Control Strategy Workshop
Sheraton Grand Incheon Hotel,...
09 - 11
Nov 202611th Microbiome Movement USA Summit
The Colonnade Hotel, Boston, M...
10 - 11
Nov 2026Extractables & Leachables Europe
Parkhotel Schӧnbrunn, Vienna,...
LATEST NEWSRead more...
Rhythm Pharmaceuticals and LG Chem Enter into Amendment to Bivamelagon Exclusive License Agreement
Rhythm Pharmaceuticals Inc announced an amendment to the global exclusive license agreement with LG Chem Ltd for bivamelagon an investigational oral smallmolecule melanocortin receptor MCR agonist The Company also announced a fiveyear term loan facility led by KKR
SCIEX Launches LeadScape Compatible with SCIEX OS Software to Accelerate High-Throughput Drug Candidate Evaluation
SCIEX a Danaher company and leader in life science analytical technologies today announced the launch of LeadScape compatible with SCIEX OS software a new highthroughput workflow solution that accelerates drug candidate evaluation Developed by Sound Analytics the software
Denali Therapeutics Receives 2026 Prix Galien USA Award for AVLAYAH® (tividenofusp alfa-eknm) as Best Biotechnology Product
Denali Therapeutics Inc announced that AVLAYAH tividenofusp alfaeknm has been recognized as the Best Biotechnology Product of by The Galien Foundation AVLAYAH is the first biologic approved by the US Food and Drug Administration FDA that is specifically designed to cross the bloodbrain barrier and...
Doximity Launches DoseCheck to Catch Dangerous AI Drug Dosing Errors Before They Reach Doctors
Doximity Inc the leading digital platform for US medical professionals has launched DoseCheck a free additional safety layer in Doximity Ask that instantly checks every AIgenerated medication dosing claim against a structured drug database to reduce treatment
Celularity and Vesalius Longevity Labs Sign Exclusive Collaboration for Peptual® Peptide APIs Manufactured in the United States
Celularity Inc a longevityfocused regenerative and cellular medicine company and Vesalius Longevity Labs Inc Vesalius a leading global peptide and longevity brand today announced that they have entered into an exclusive manufacturing agreement to establish a dedicated firstofitskind US final stage
Rakovina Therapeutics and Celvion Therapeutics Complete AI Analysis Identifying Priority Cancer Indications for Brain-Penetrant ATR Inhibitor Program
Rakovina Therapeutics Inc a biopharmaceutical company advancing innovative cancer therapies through AIpowered drug discovery and Bostonbased Celvion Therapeutics Celvion today announced the completion of the first analysis in their collaboration using Celvions EMphora
